ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1118

Bone Marrow Lesion Scores in Patients with Knee Osteoarthritis Undergoing Tibial Osteotomy: Reliability and Concurrent Validity of the Knee Inflammation MRI Scoring System (KIMRISS)

Jenna Schulz1, Trevor Birmingham1, Walter Maksymowych2, Robert G Lambert3, Stephany Pritchett4, Frank Beier1, J. Robert Giffin5 and Tom Appleton6, 1Western University, London, Canada, 2University of Alberta, Edmonton, AB, Canada, 3University of Alberta and CARE Arthritis, Edmonton, AB, Canada, 4London Health Sciences Centre, London, Canada, 5Western University and London Health Sciences Centre, London, Canada, 6The University of Western Ontario, LONDON, ON, Canada

Meeting: ACR Convergence 2020

Keywords: Imaging, Inflammation, Magnetic resonance imaging (MRI), Osteoarthritis, surgery

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Bone marrow lesions (BMLs) commonly occur in knee osteoarthritis (OA) and are associated with increased risk of cartilage damage and pain. The Knee Inflammation MRI Scoring System (KIMRISS) is a semi-quantitative (score range 0-500) grading tool designed to evaluate features of inflammation in patients with knee OA. Therefore, we assessed 1) inter-rater reliability of KIMRISS BML scores between expert readers and a trainee reader before and 1-year BML scores before and 1-year after medial opening wedge HTO and 2) concurrent validity of semi-quantitative (KIMRISS) and quantitative (manual segmentation) measures of BMLs at baseline.

Methods: Thirty-four patients with varus alignment and medial compartment knee OA undergoing unilateral HTO were included. 3-Tesla MRIs were acquired of both knees pre and 1-year post HTO, after surgical removal of hardware. Femoral BML scores in the medial and lateral compartments were assessed on images blinded to limb and time by masking evidence of surgery. Three raters independently scored the same 136 scans (two limbs at two time points for each patient) using the KIMRISS. Additionally, one rater manually segmented femoral BMLs. Reliability of BML change scores in the medial and lateral compartment of the surgical limb were evaluated by calculating intraclass correlation coefficients (ICC) and Bland-Altman plots with 80% Limits of Agreement (LoA). Correlations between KIMRISS and manual segmentation values on the pre-operative surgical limb were evaluated using Pearson’s correlation coefficients (r).

Results: Descriptive statistics for KIMRISS scores are reported in Figure 1. The mean change in the surgical limb (± SD) was 0.54 ± 4.78 in the medial compartment and 1.00 ± 3.62 in the lateral compartment. Changes following surgery varied considerably but were detected by all three raters (Figure 2). When combining all three raters, the ICC (95% confidence interval) was 0.74 (0.59, 0.85) for the medial compartment and 0.71 (0.55, 0.83) for the lateral compartment. Paired rater ICCs ranged from 0.56-0.83. The 80% LoA was -3.57 to 5.44 for the medial compartment and -1.57 to 3.47 for the lateral compartment (Table 1). Paired rater LoA ranged from -5.07 to 7.70. Semi-quantitative and quantitative BML measures were positively correlated for the medial (r=0.54) and the lateral (r=0.39) compartments.

Conclusion: The KIMRISS can reliably detect small differences between femoral BML scores after HTO and can be learned by a trainee reader both efficiently and effectively. The KIMRISS BML scores are moderately correlated with scores from manual segmentation. These findings support the inter-rater reliability, concurrent validity and feasibility of KIMRISS compartment-specific BML scoring

Fig 1. Means and standard deviations for KIMRISS femoral BML scores in the medial and lateral compartments for surgical and contralateral knees.

Fig 2. Change after surgery in the femoral BML score in both the medial (a) and lateral (b) compartments of the surgical knee for all three raters individually, as well as the average.

Table 1: Intraclass correlations (95% Confidence Intervals) (a,b) and 80% Limits of Agreement (c,d) for change in BML scores in the surgical knee in the medial and lateral compartments. Rater 1 = trainee, raters 2-3 = experts (one MSK radiologist and one rheumatologist).


Disclosure: J. Schulz, None; T. Birmingham, None; W. Maksymowych, AbbVie, 2, 5, Janssen, 5, Lilly, 5, Pfizer, 2, 5, Novartis, 2, 5, Gilead, 5, UCB Pharma, 5, Boehringer Ingelheim, 5, Galapagos, 5; R. Lambert, None; S. Pritchett, None; F. Beier, None; J. Giffin, None; T. Appleton, Abbvie, 2, 5, 8, CaRE Arthritis, 2, Gilead, 2, 5, 8, Pfizer, 2, 5, 8, Servier/Galapagos, 2, Amgen, 5, 8, BMS, 5, 8, Celgene, 5, 8, Janssen, 5, 8, Merck, 5, 8, Novartis, 5, 8, Hoffman LaRO=oche, 5, 8, Sandoz, 5, 8, Sanofi-Genzyme, 5, 8, UCB, 5, 8, Ontario Rheumatology Association, 6, Canadian Rheumatology Association, 6, American College of Rheumatology, 6.

To cite this abstract in AMA style:

Schulz J, Birmingham T, Maksymowych W, Lambert R, Pritchett S, Beier F, Giffin J, Appleton T. Bone Marrow Lesion Scores in Patients with Knee Osteoarthritis Undergoing Tibial Osteotomy: Reliability and Concurrent Validity of the Knee Inflammation MRI Scoring System (KIMRISS) [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/bone-marrow-lesion-scores-in-patients-with-knee-osteoarthritis-undergoing-tibial-osteotomy-reliability-and-concurrent-validity-of-the-knee-inflammation-mri-scoring-system-kimriss/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-marrow-lesion-scores-in-patients-with-knee-osteoarthritis-undergoing-tibial-osteotomy-reliability-and-concurrent-validity-of-the-knee-inflammation-mri-scoring-system-kimriss/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology